Psilocybin-Assisted Psychotherapy Trial for Cancer Survivors Launched
A clinical trial is underway to evaluate the feasibility and safety of psilocybin-assisted psychotherapy for cancer survivors experiencing depression and/or anxiety.
Asset / Drug
Drug and asset intelligence for Psilocybin-Assisted with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.